These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24759760)

  • 1. Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California.
    Budzik JM; Jarlsberg LG; Higashi J; Grinsdale J; Hopewell PC; Kato-Maeda M; Nahid P
    PLoS One; 2014; 9(4):e95645. PubMed ID: 24759760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009.
    Kurbatova EV; Cavanaugh JS; Dalton T; Click ES; Cegielski JP
    Clin Infect Dis; 2013 Oct; 57(8):1081-93. PubMed ID: 23840002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
    Che Y; Bo D; Lin X; Chen T; He T; Lin Y
    BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK
    BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
    Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM
    BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
    BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.
    Hannan MM; Desmond EP; Morlock GP; Mazurek GH; Crawford JT
    J Clin Microbiol; 2001 Feb; 39(2):647-50. PubMed ID: 11158123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
    Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
    Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of pyrazinamide resistance in consecutive multidrug-resistant
    Mansjo M; Werngren J; Hoffner S
    Int J Mycobacteriol; 2017; 6(2):156-161. PubMed ID: 28559517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
    Maslov DA; Zaĭchikova MV; Chernousova LN; Shur KV; Bekker OB; Smirnova TG; Larionova EE; Andreevskaya SN; Zhang Y; Danilenko VN
    Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of pyrazinamide-monoresistant Mycobacterium tuberculosis in Quebec.
    Yee DP; Menzies D; Brassard P
    Int J Tuberc Lung Dis; 2012 May; 16(5):604-9. PubMed ID: 22409887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global status of phenotypic pyrazinamide resistance in
    Wang Z; Tang Z; Heidari H; Molaeipour L; Ghanavati R; Kazemian H; Koohsar F; Kouhsari E
    J Chemother; 2023 Nov; 35(7):583-595. PubMed ID: 37211822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis.
    Modlin SJ; Marbach T; Werngren J; Mansjö M; Hoffner SE; Valafar F
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients.
    Louw GE; Warren RM; Donald PR; Murray MB; Bosman M; Van Helden PD; Young DB; Victor TC
    Int J Tuberc Lung Dis; 2006 Jul; 10(7):802-7. PubMed ID: 16848344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
    Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
    BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.
    Xu P; Wu J; Yang C; Luo T; Shen X; Zhang Y; Nsofor CA; Zhu G; Gicquel B; Gao Q
    Tuberculosis (Edinb); 2016 May; 98():56-61. PubMed ID: 27156619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Kuhlin J; Smith C; Khaemraev A; Tigay Z; Parpieva N; Tillyashaykhov M; Achar J; Hajek J; Greig J; du Cros P; Moore D
    Int J Tuberc Lung Dis; 2018 May; 22(5):544-550. PubMed ID: 29663960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
    Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
    Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Sheed Khan A; Nadeem T; Zeb MT; Masood N; Afzal MT
    Microb Drug Resist; 2018 Nov; 24(9):1417-1421. PubMed ID: 29584579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.